• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Professor Gianvito Martino

Gianvito Martino received his Medical Degree in 1987 from the University of Pavia (Italy) where he completed his residency in Neurology in 1991. In 1990, he was a Visiting Scientist at the Department of Neurology of the Karolinska Institute (Stockholm, Sweden) and, from 1991 to 1992, he held the position of Research Associate at the Department of Neurology of the University of Chicago (Chicago, IL, USA). From 1992 to 2008, he worked first as Senior Scientist and then as Director of the Neuroimmunology Unit of the San Raffaele Scientific Institute in Milan (Italy) where, from 2008 to 2016, he acts as Director of the Division of Neuroscience. From 2016, he has been appointed as Scientific Director of the San Raffaele Scientific Institute. He is full professor of Experimental Biology at the San Raffaele Vita-Salute University in Milan and, from 2009 to 2017, he was appointed Honorary Professor at Queen Mary University of London. He has been the Scientific Secretary (from 1998 to 2003) and the President (from 2009 to 2012) of the Italian Neuroimmunology Society (AINI). He is the founder and the Scientific Coordinator of the European School of Neuroimmunology (ESNI) and of the Global Schools of Neuroimmunology (GSNI). Within the International Society for Neuroimmunology (ISNI), he served as advisory board member (from 2002 to 2010), Vice President (from 2010 to 2012) and President (from 201 to 2014). He has been a member of the scientific committee of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), the Italian Multiple Sclerosis Foundation (FISM), and the Multiple Sclerosis International Federation (MSIF). He served as member of the Grant Reviewing Panel of the UK Multiple Sclerosis Society from 2007 to 2015 and, from 2012 to 2016, he served as a member of the Wellcome Trust’s Peer Review College. From 2015 he serves as Panel Member of the European Research Council (ERC). He is co-author of more than 250 original articles and book chapters. His scientific interests range from the elucidation of the pathogenic mechanisms of immune-mediated central nervous system disorders to the development of gene and stem cell-based therapies for the treatment of these disorders.

« Professor Fredrik Piehl
Professor Darin Okuda »

The 18th Malvern Diabetic Foot Conference
Wednesday, 7 – Friday, 9 July 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Cardiology, Diabetes & Nephrology at the Limits 2022
Monday, 4 & Tuesday, 5 April 2022, London,UK

Cardiology, Diabetes & Nephrology at the Limits Canada
Tuesday, 24 & Wednesday, 25 May 2022, Toronto, Canada

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info